The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Schuster, S. J., Bishop, M. R., Tam, C. S., Waller, E. K., Borchmann, P., McGuirk, J. P., Jäger, U., Jaglowski, S., Andreadis, C., Westin, J. R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1804980 · Cited by 4,112
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Molecular therapies and precision medicine for hepatocellular carcinoma
Llovet, J. M., Montal, R., Sia, D., & Finn, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0073-4 · Cited by 1,938
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Van Raamsdonk, C. D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2009) · Nature · doi:10.1038/nature07586 · Cited by 1,623
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Plaks, V., Kong, N., & Werb, Z. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.02.015 · Cited by 1,557
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,464
Cancer Stem Cells: Current Status and Evolving Complexities
Visvader, J. E., & Lindeman, G. J. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.007 · Cited by 1,287
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
Rudin, C. M., Hann, C. L., Laterra, J., Yauch, R. L., Callahan, C. A., Fu, L., Holcomb, T., Stinson, J., Gould, S. E., Coleman, B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902903 · Cited by 1,019
Tackling the cancer stem cells — what challenges do they pose?
Pattabiraman, D. R., & Weinberg, R. A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4253 · Cited by 990
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Sia, D., Jiao, Y., Martinez-Quetglas, I., Kuchuk, O., Villacorta-Martin, C., Castro de Moura, M., Putra, J., Camprecios, G., Bassaganyas, L., Akers, N., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.007 · Cited by 976
Recurrent R-spondin fusions in colon cancer
Seshagiri, S., Stawiski, E. W., Durinck, S., Modrusan, Z., Storm, E. E., Conboy, C. B., Chaudhuri, S., Guan, Y., Janakiraman, V., Jaiswal, B. S., et al. (2012) · Nature · doi:10.1038/nature11282 · Cited by 960
Notch signaling: simplicity in design, versatility in function
Andersson, E. R., Sandberg, R., & Lendahl, U. (2011) · Development · doi:10.1242/dev.063610 · Cited by 950
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Zhou, B.-B. S., Zhang, H., Damelin, M., Geles, K. G., Grindley, J. C., & Dirks, P. B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2137 · Cited by 841
Hedgehog signalling in cancer formation and maintenance
di Magliano, M. P., & Hebrok, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1229 · Cited by 829
Jordan, C., Upchurch, D., Szilvassy, S., Guzman, M., Howard, D., Pettigrew, A., Meyerrose, T., Rossi, R., Grimes, B., Rizzieri, D., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401903 · Cited by 821
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Lauth, M., Bergström, Å., Shimokawa, T., & Toftgård, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609699104 · Cited by 782
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Marzec, M., Zhang, Q., Goradia, A., Raghunath, P. N., Liu, X., Paessler, M., Wang, H. Y., Wysocka, M., Cheng, M., Ruggeri, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810958105 · Cited by 728
Maximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2192 · Cited by 717
Wnt/beta-catenin pathway: modulating anticancer immune response
Pai, S. G., Carneiro, B. A., Mota, J. M., Costa, R., Leite, C. A., Barroso-Sousa, R., Kaplan, J. B., Chae, Y. K., & Giles, F. J. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0471-6 · Cited by 703
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 675
Gurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.010 · Cited by 602
Sikic, B. I., Lakhani, N., Patnaik, A., Shah, S. A., Chandana, S. R., Rasco, D., Colevas, A. D., O’Rourke, T., Narayanan, S., Papadopoulos, K., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02018 · Cited by 599
Loss of β-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo
Zhao, C., Blum, J., Chen, A., Kwon, H. Y., Jung, S. H., Cook, J. M., Lagoo, A., & Reya, T. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.003 · Cited by 592
YAP and TAZ: a nexus for Hippo signaling and beyond
Hansen, C. G., Moroishi, T., & Guan, K.-L. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.05.002 · Cited by 574
Rudin, C. M., Pietanza, M. C., Bauer, T. M., Ready, N., Morgensztern, D., Glisson, B. S., Byers, L. A., Johnson, M. L., Burris, H. A., Robert, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30565-4 · Cited by 574
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
Korkaya, H., Paulson, A., Iovino, F., & Wicha, M. S. (2008) · Oncogene · doi:10.1038/onc.2008.207 · Cited by 556
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C. C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 553
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Amakye, D., Jagani, Z., & Dorsch, M. (2013) · Nature Medicine · doi:10.1038/nm.3389 · Cited by 547
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., Clemons, K. V., Chong, C. R., Chang, K. S., Fereshteh, M., Gardner, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.027 · Cited by 527
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Saygin, C., Matei, D., Majeti, R., Reizes, O., & Lathia, J. D. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.017 · Cited by 517
Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
Dierks, C., Beigi, R., Guo, G.-R., Zirlik, K., Stegert, M. R., Manley, P., Trussell, C., Schmitt-Graeff, A., Landwerlin, K., Veelken, H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.003 · Cited by 517
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Khramtsov, A. I., Khramtsova, G. F., Tretiakova, M., Huo, D., Olopade, O. I., & Goss, K. H. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091125 · Cited by 509
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Wang, Y., Xu, X., Maglic, D., Dill, M. T., Mojumdar, K., Ng, P. K.-S., Jeong, K. J., Tsang, Y. H., Moreno, D., Bhavana, V. H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.001 · Cited by 500
Cortes, J. E., Heidel, F. H., Hellmann, A., Fiedler, W., Smith, B. D., Robak, T., Montesinos, P., Pollyea, D. A., DesJardins, P., Ottmann, O., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0312-9 · Cited by 496
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
Thompson, B. J., Buonamici, S., Sulis, M. L., Palomero, T., Vilimas, T., Basso, G., Ferrando, A., & Aifantis, I. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070872 · Cited by 480
Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma
Peacock, C. D., Wang, Q., Gesell, G. S., Corcoran-Schwartz, I. M., Jones, E., Kim, J., Devereux, W. L., Rhodes, J. T., Huff, C. A., Beachy, P. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611682104 · Cited by 478
RNF43 is frequently mutated in colorectal and endometrial cancers
Giannakis, M., Hodis, E., Jasmine Mu, X., Yamauchi, M., Rosenbluh, J., Cibulskis, K., Saksena, G., Lawrence, M. S., Qian, Z. R., Nishihara, R., et al. (2014) · Nature Genetics · doi:10.1038/ng.3127 · Cited by 470
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
Lu, H., Clauser, K. R., Tam, W. L., Fröse, J., Ye, X., Eaton, E. N., Reinhardt, F., Donnenberg, V. S., Bhargava, R., Carr, S. A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3041 · Cited by 459
Robinson, G. W., Orr, B. A., Wu, G., Gururangan, S., Lin, T., Qaddoumi, I., Packer, R. J., Goldman, S., Prados, M. D., Desjardins, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.1591 · Cited by 448
Self-citationCui, T. X., Kryczek, I., Zhao, L., Zhao, E., Kuick, R., Roh, M. H., Vatan, L., Szeliga, W., Mao, Y., Thomas, D. G., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.025 · Cited by 427
Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
Jiang, X., Hao, H.-X., Growney, J. D., Woolfenden, S., Bottiglio, C., Ng, N., Lu, B., Hsieh, M. H., Bagdasarian, L., Meyer, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307218110 · Cited by 414
Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
Palacios, J., & Gamallo, C. (1998) · PubMed · Cited by 407
Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
Atwood, S. X., Sarin, K. Y., Whitson, R. J., Li, J. R., Kim, G., Rezaee, M., Ally, M. S., Kim, J., Yao, C., Chang, A. L. S., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.002 · Cited by 404
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Tanas, M. R., Sboner, A., Oliveira, A. M., Erickson-Johnson, M. R., Hespelt, J., Hanwright, P. J., Flanagan, J., Luo, Y., Fenwick, K., Natrajan, R., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002409 · Cited by 401
The Hedgehog's tale: developing strategies for targeting cancer
Ng, J. M. Y., & Curran, T. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3079 · Cited by 398
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Paczulla, A. M., Rothfelder, K., Raffel, S., Konantz, M., Steinbacher, J., Wang, H., Tandler, C., Mbarga, M., Schaefer, T., Falcone, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1410-1 · Cited by 391
Alterations of the Notch pathway in lung cancer
Westhoff, B., Colaluca, I. N., D'Ario, G., Donzelli, M., Tosoni, D., Volorio, S., Pelosi, G., Spaggiari, L., Mazzarol, G., Viale, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907781106 · Cited by 387
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., Tsui, V., Durham, A. B., Dlugosz, A. A., Haverty, P. M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.001 · Cited by 382
Organoid cultures for the analysis of cancer phenotypes
Sachs, N., & Clevers, H. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.012 · Cited by 371
Morris, J. P., Cano, D. A., Sekine, S., Wang, S. C., & Hebrok, M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40045 · Cited by 366
Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think
Lobry, C., Oh, P., & Aifantis, I. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111855 · Cited by 356
Cancer stem cells – old concepts, new insights
Vermeulen, L., Sprick, M. R., Kemper, K., Stassi, G., & Medema, J. P. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.20 · Cited by 352
Beauchamp, E. M., Ringer, L., Bulut, G., Sajwan, K. P., Hall, M. D., Lee, Y.-C., Peaceman, D., Özdemirli, M., Rodriguez, O., Macdonald, T. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42874 · Cited by 351
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Di Tomaso, T., Mazzoleni, S., Wang, E., Sovena, G., Clavenna, D., Franzin, A., Mortini, P., Ferrone, S., Doglioni, C., Marincola, F. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2730 · Cited by 344
Stem Cell Lineage Infidelity Drives Wound Repair and Cancer
Ge, Y., Gomez, N. C., Adam, R. C., Nikolova, M., Yang, H., Verma, A., Lu, C. P.-J., Polak, L., Yuan, S., Elemento, O., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.042 · Cited by 343
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Wang, Y., Chen, M., Wu, Z., Tong, C., Dai, H., Guo, Y., Liu, Y., Huang, J., Lv, H., Luo, C., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1440169 · Cited by 338
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2743 · Cited by 334
Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Yang, L., Xie, G., Fan, Q., & Xie, J. (2010) · Oncogene · doi:10.1038/onc.2009.392 · Cited by 331
Morgan, R. A., Johnson, L. A., Davis, J. L., Zheng, Z., Woolard, K. D., Reap, E. A., Feldman, S. A., Chinnasamy, N., Kuan, C.-T., Song, H., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.041 · Cited by 311
Delmas, V., Beermann, F., Martinozzi, S., Carreira, S., Ackermann, J., Kumasaka, M., Denat, L., Goodall, J., Luciani, F., Viros, A., et al. (2007) · Genes & Development · doi:10.1101/gad.450107 · Cited by 311
Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
Cottini, F., Hideshima, T., Xu, C., Sattler, M., Dori, M., Agnelli, L., ten Hacken, E., Bertilaccio, M. T., Antonini, E., Neri, A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3562 · Cited by 309
Kim, E. J., Sahai, V., Abel, E. V., Griffith, K. A., Greenson, J. K., Takebe, N., Khan, G. N., Blau, J. L., Craig, R., Balis, U. G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1269 · Cited by 306
Self-citationJørgensen, H. G., Allan, E. K., Jordanides, N. E., Mountford, J. C., & Holyoake, T. L. (2007) · Blood · doi:10.1182/blood-2006-11-057521 · Cited by 306
Müller-Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., Sargin, B., Köhler, G., Stelljes, M., Puccetti, E., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2890-2904.2004 · Cited by 303
Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
Miao, Y., Yang, H., Levorse, J., Yuan, S., Polak, L., Sribour, M., Singh, B., Rosenblum, M. D., & Fuchs, E. (2019) · Cell · doi:10.1016/j.cell.2019.03.025 · Cited by 299
Kim, S.-Y., Kang, J. W., Song, X., Kim, B. K., Yoo, Y. D., Kwon, Y. T., & Lee, Y. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.007 · Cited by 297
Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Schatton, T., Schütte, U., Frank, N. Y., Zhan, Q., Hoerning, A., Robles, S. C., Zhou, J., Hodi, F. S., Spagnoli, G. C., Murphy, G. F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1592 · Cited by 287
Basset-Séguin, N., Hauschild, A., Kunstfeld, R., Grob, J., Dréno, B., Mortier, L., Ascierto, P. A., Licitra, L., Dutriaux, C., Thomas, L., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.08.022 · Cited by 286
Targeting Notch signalling pathway of cancer stem cells
Venkatesh, V., Nataraj, R., Thangaraj, G. S., Karthikeyan, M., Gnanasekaran, A., Kaginelli, S. B., Kuppanna, G., Kallappa, C. G., & Basalingappa, K. M. (2018) · Stem Cell Investigation · doi:10.21037/sci.2018.02.02 · Cited by 275
β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells
Yeung, J., Esposito, M. T., Gandillet, A., Zeisig, B. B., Griessinger, E., Bonnet, D., & So, C. W. E. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.032 · Cited by 270
Tolcher, A. W., Messersmith, W. A., Mikulski, S. M., Papadopoulos, K. P., Kwak, E. L., Gibbon, D. G., Patnaik, A., Falchook, G. S., Dasari, A., Shapiro, G. I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8282 · Cited by 268
Panciera, T., Azzolin, L., Fujimura, A., Di Biagio, D., Frasson, C., Bresolin, S., Soligo, S., Basso, G., Bicciato, S., Rosato, A., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.08.009 · Cited by 259
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
Kim, W., Khan, S. K., Gvozdenovic-Jeremic, J., Kim, Y., Dahlman, J., Kim, H., Park, O., Ishitani, T., Jho, E.-H., Gao, B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88486 · Cited by 244
Self-citationMulti-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation
Guo, W., Lasky, J. L., Chang, C.-J., Mosessian, S., Lewis, X., Xiao, Y., Yeh, J. E., Chen, J. Y., Iruela-Arispe, M. L., Varella-Garcia, M., et al. (2008) · Nature · doi:10.1038/nature06933 · Cited by 241
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Ames, E., Canter, R. J., Grossenbacher, S. K., Mac, S., Chen, M., Smith, R. C., Hagino, T., Perez-Cunningham, J., Sckisel, G. D., Urayama, S., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500447 · Cited by 235
TCR-Mediated Notch Signaling Regulates Proliferation and IFN-γ Production in Peripheral T Cells
Palaga, T., Miele, L., Golde, T. E., & Osborne, B. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3019 · Cited by 235
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
Balli, D., Rech, A. J., Stanger, B. Z., & Vonderheide, R. H. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2128 · Cited by 235
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Deng, Z., Wu, Y., Ma, W., Zhang, S., & Zhang, Y.-Q. (2015) · BMC Immunology · doi:10.1186/s12865-014-0064-x · Cited by 232
Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
Espinoza, I., & Miele, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.027 · Cited by 232
Swords, R. T., Erba, H. P., DeAngelo, D. J., Bixby, D. L., Altman, J. K., Maris, M., Hua, Z., Blakemore, S. J., Faessel, H., Sedarati, F., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13323 · Cited by 231
Tumor-Initiating Cells Are Rare in Many Human Tumors
Ishizawa, K., Rasheed, Z. A., Karisch, R., Wang, Q., Kowalski, J., Susky, E., Pereira, K., Karamboulas, C., Moghal, N., Rajeshkumar, N. V., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.009 · Cited by 229
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Cioffi, M., Trabulo, S., Hidalgo, M., Costello, E., Greenhalf, W., Erkan, M., Kleeff, J., Sainz, B., & Heeschen, C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1399 · Cited by 229
Deangelo, D. J., Stone, R. M., Silverman, L. B., Stock, W., Attar, E. C., Fearen, I., Dallob, A., Matthews, C., Stone, J., Freedman, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.6585 · Cited by 229
Heidel, F. H., Bullinger, L., Feng, Z., Wang, Z., Neff, T. A., Stein, L., Kalaitzidis, D., Lane, S. W., & Armstrong, S. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.017 · Cited by 225
Brown, C. E., Starr, R., Aguilar, B., Shami, A. F., Martinez, C., D'Apuzzo, M., Barish, M. E., Forman, S. J., & Jensen, M. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1669 · Cited by 225
Lee, Y., Shin, J. H., Longmire, M., Wang, H., Kohrt, H. E., Chang, H. Y., & Sunwoo, J. B. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2665 · Cited by 219
Messersmith, W. A., Shapiro, G. I., Cleary, J. M., Jimeno, A., Dasari, A., Huang, B., Shaik, M. N., Cesari, R., Zheng, X., Reynolds, J. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0607 · Cited by 218
Xu, Q., Liu, G., Yuan, X., Xu, M., Wang, H., Ji, J., Konda, B., Black, K. L., & Yu, J. S. (2009) · Stem Cells · doi:10.1002/stem.102 · Cited by 217
Dikkopf-1 as a Novel Serologic and Prognostic Biomarker for Lung and Esophageal Carcinomas
Yamabuki, T., Takano, A., Hayama, S., Ishikawa, N., Kato, T., Miyamoto, M., Ito, T., Ito, H., Miyagi, Y., Nakayama, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3369 · Cited by 213
Gajjar, A., Stewart, C. F., Ellison, D. W., Kaste, S., Kun, L. E., Packer, R. J., Goldman, S., Chintagumpala, M., Wallace, D., Takebe, N., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1425 · Cited by 211
Self-citationJimeno, A., Gordon, M., Chugh, R., Messersmith, W., Mendelson, D., Dupont, J., Stagg, R., Kapoun, A. M., Xu, L., Uttamsingh, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2157 · Cited by 209
Canonical Wnt Signaling Is Required for Pancreatic Carcinogenesis
Zhang, Y., Morris, J. P., Yan, W., Schofield, H. K., Gurney, A., Simeone, D. M., Millar, S. E., Hoey, T., Hebrok, M., & Pasca di Magliano, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4384 · Cited by 208
Molecular genetics and targeted therapy of WNT-related human diseases (Review)
Katoh, M., & Katoh, M. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3071 · Cited by 207
Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
Wang, W., Li, N., Li, X., Tran, M. K., Han, X., & Chen, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.014 · Cited by 206
Paracrine Hedgehog Signaling in Cancer
Theunissen, J.-W., & de Sauvage, F. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0756 · Cited by 201
Swords, R. T., Coutre, S., Maris, M. B., Zeidner, J. F., Foran, J. M., Cruz, J., Erba, H. P., Berdeja, J. G., Tam, W., Vardhanabhuti, S., et al. (2018) · Blood · doi:10.1182/blood-2017-09-805895 · Cited by 199
Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells
Wang, B., Wang, Q., Wang, Z., Jiang, J., Yu, S.-C., Ping, Y.-F., Yang, J., Xu, S.-L., Ye, X.-Z., Xu, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2563 · Cited by 198
Overview of CDK9 as a target in cancer research
Morales, F., & Giordano, A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1138186 · Cited by 196
Song, S., Xie, M., Scott, A. W., Jin, J., Ma, L., Dong, X., Skinner, H. D., Johnson, R. L., Ding, S., & Ajani, J. A. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0560 · Cited by 196
Wei, P., Walls, M., Qiu, M., Ding, R., Denlinger, R. H., Wong, A., Tsaparikos, K., Jani, J. P., Hosea, N., Sands, M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0034 · Cited by 195
Choi, M. Y., Widhopf, G. F., Ghia, E. M., Kidwell, R. L., Hasan, M. K., Yu, J., Rassenti, L. Z., Chen, L., Chen, Y., Pittman, E., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.018 · Cited by 192
Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
van Andel, H., Kocemba, K. A., Spaargaren, M., & Pals, S. T. (2019) · Leukemia · doi:10.1038/s41375-019-0404-1 · Cited by 188
Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
Polydorou, C., Mpekris, F., Papageorgis, P., Voutouri, C., & Stylianopoulos, T. (2017) · Oncotarget · doi:10.18632/oncotarget.15534 · Cited by 185
Kummar, S., O'Sullivan Coyne, G., Do, K. T., Turkbey, B., Meltzer, P. S., Polley, E., Choyke, P. L., Meehan, R., Vilimas, R., Horneffer, Y., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.1994 · Cited by 183
Berlin, J., Bendell, J. C., Hart, L. L., Firdaus, I., Gore, I., Hermann, R. C., Mulcahy, M. F., Zalupski, M. M., Mackey, H. M., Yauch, R. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1800 · Cited by 181
Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
Gregory, M. A., Phang, T. L., Neviani, P., Alvarez-Calderon, F., Eide, C. A., O'Hare, T., Zaberezhnyy, V., Williams, R. T., Druker, B. J., Perrotti, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.025 · Cited by 180
Antonarakis, E. S., Heath, E. I., Smith, D. C., Rathkopf, D., Blackford, A. L., Danila, D. C., King, S., Frost, A., Ajiboye, A. S., Zhao, M., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-314 · Cited by 180
Wnt/β-Catenin Signaling in T-Cell Immunity and Cancer Immunotherapy
Gattinoni, L., Ji, Y., & Restifo, N. P. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0356 · Cited by 175
Singh, R. R., Kunkalla, K., Qu, C., Schlette, E. J., Neelapu, S. S., Samaniego, F., & Vega, F. (2011) · Oncogene · doi:10.1038/onc.2011.195 · Cited by 168
Differential niche and Wnt requirements during acute myeloid leukemia progression
Lane, S., Wang, J. Y., Celso, C. L., Ragu, C., Bullinger, L., Sykes, S. M., Ferraro, F., Shterental, S., Lin, C. P., Gilliland, D. G., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345165 · Cited by 164
Beard, R. E., Zheng, Z., Lagisetty, K. H., Burns, W. R., Tran, E., Hewitt, S. M., Abate-Daga, D., Rosati, S. F., Fine, H. A., Ferrone, S., et al. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-25 · Cited by 163
Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells
Visus, C., Wang, Y., Lozano-Leon, A., Ferris, R. L., Silver, S., Szczepanski, M. J., Brand, R. E., Ferrone, C. R., Whiteside, T. L., Ferrone, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1111 · Cited by 162
VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
Jiao, S., Li, C., Qian, H., Miao, H., Zhang, L., Li, L., & Zhou, Z. (2017) · Nature Communications · doi:10.1038/ncomms14058 · Cited by 161
The Hippo Pathway: Immunity and Cancer
Taha, Z., van Rensburg, H. J. J., & Yang, X. (2018) · Cancers · doi:10.3390/cancers10040094 · Cited by 161
Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer
Pelullo, M., Zema, S., Nardozza, F., Checquolo, S., Screpanti, I., & Bellavia, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00711 · Cited by 160
Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches
Pan, Q., Li, Q., Liu, S., Ning, N., Zhang, X., Xu, Y., Chang, A. E., & Wicha, M. S. (2015) · Stem Cells · doi:10.1002/stem.2039 · Cited by 158
TGF-β Signaling Alterations and Colon Cancer
Bellam, N., & Pasche, B. (2010) · Cancer treatment and research · doi:10.1007/978-1-4419-6033-7_5 · Cited by 158
Menke-van der Houven van Oordt, C. W., Gomez-Roca, C., van Herpen, C., Coveler, A. L., Mahalingam, D., Verheul, H. M. W., van der Graaf, W. T. A., Christen, R., Rüttinger, D., Weigand, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11098 · Cited by 158
Rudin, C. M., Brahmer, J. R., Juergens, R. A., Hann, C. L., Ettinger, D. S., Sebree, R., Smith, R. D., Aftab, B. T., Huang, P., & Liu, J. O. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828c3950 · Cited by 157
Role of Notch signaling in colorectal cancer
Qiao, L., & Wong, B. C. Y. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp236 · Cited by 154
Adeegbe, D. O., Liu, Y., Lizotte, P. H., Kamihara, Y., Aref, A. R., Almonte, C. G., Dries, R., Li, Y., Liu, S., Wang, X., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1020 · Cited by 154
Notch activation inhibits AML growth and survival: a potential therapeutic approach
Kannan, S., Sutphin, R. M., Hall, M. G., Golfman, L. S., Fang, W., Nolo, R. M., Akers, L. J., Hammitt, R. A., McMurray, J. S., Kornblau, S. M., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121527 · Cited by 152
Chiorean, E. G., LoRusso, P. M., Strother, R. M., Diamond, J. R., Younger, A., Messersmith, W. A., Adriaens, L., Liu, L., Kao, R., DiCioccio, A. T., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2797 · Cited by 152
A phase II study of RO4929097 in metastatic colorectal cancer
Strosberg, J., Yeatman, T. J., Weber, J., Coppola, D., Schell, M. J., Han, G., Almhanna, K., Kim, R. D., Valone, T., Jump, H., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.056 · Cited by 152
Hedgehog signaling maintains chemoresistance in myeloid leukemic cells
Queiroz, K. C. S., Ruela-de-Sousa, R. R., Fuhler, G. M., Aberson, H. L., Ferreira, C. V., Peppelenbosch, M. P., & Spek, C. A. (2010) · Oncogene · doi:10.1038/onc.2010.375 · Cited by 152
Valencia, A., Román‐Gómez, J., Cervera, J., Such, E., Barragán, E., Bolufer, P., Moscardó, F., Sanz, G. F., & Sanz, M. Á. (2009) · Leukemia · doi:10.1038/leu.2009.86 · Cited by 149
STAT3: A Target to Enhance Antitumor Immune Response
Lee, H., Pal, S. K., Reckamp, K. L., Figlin, R. A., & Yu, H. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_51 · Cited by 145
Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer
Yang, S., Wang, B., Chunying, G., Wu, B., Cai, C., Wang, M., Zhang, B., Liu, T., & Yang, P. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0910506 · Cited by 143
Pandya, K., Meeke, K., Clementz, A. G., Rogowski, A., Roberts, J., Miele, L., Albain, K. S., & Osipo, C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.321 · Cited by 140
Theocharides, A. P. A., Jin, L., Cheng, P.-Y., Prasolava, T. K., Malko, A. V., Ho, J., Poeppl, A. G., van Rooijen, N., Minden, M. D., Danska, J. S., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120502 · Cited by 139
Ferrarotto, R., Eckhardt, G., Patnaik, A., LoRusso, P., Faoro, L., Heymach, J. V., Kapoun, A. M., Xu, L., & Munster, P. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy171 · Cited by 138
Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology
Kagey, M. H., & He, X. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13894 · Cited by 138
Cancer stem cells: Regulation programs, immunological properties and immunotherapy
Zhang, D., Tang, D. G., & Rycaj, K. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.05.001 · Cited by 137
Cook, N., Basu, B., Smith, D.-M., Gopinathan, A., Evans, J., Steward, W. P., Palmer, D. H., PROPPER, D. J., Venugopal, B., Hategan, M., et al. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.495 · Cited by 136
Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
Lee, M. J., Hatton, B. A., Villavicencio, E. H., Khanna, P. C., Friedman, S. D., Ditzler, S. H., Pullar, B. J., Robison, K. E., White, K., Tunkey, C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114718109 · Cited by 134
Dll4-Notch signaling as a therapeutic target in tumor angiogenesis
Kuhnert, F., Kirshner, J. R., & Thurston, G. (2011) · Vascular Cell · doi:10.1186/2045-824x-3-20 · Cited by 134
Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma
Chim, C. S., Pang, R., Fung, T. K., Choi, C.-L., & Liang, R. H. S. (2007) · Leukemia · doi:10.1038/sj.leu.2404939 · Cited by 133
Kaye, S. B., Fehrenbacher, L., Holloway, R. W., Amit, A., Karlan, B. Y., Slomovitz, B. M., Sabbatini, P. J., Fu, L., Yauch, R. L., Chang, I., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1796 · Cited by 131
Allensworth, J. L., Sauer, S. J., Lyerly, H. K., Morse, M. A., & Devi, G. R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2352-6 · Cited by 130
Hedgehog Signal Transduction: From Flies to Vertebrates
Murone, M., Rosenthal, A., & de Sauvage, F. J. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4676 · Cited by 127
Notch Shapes the Innate Immunophenotype in Breast Cancer
Shen, Q., Cohen, B. L., Zheng, W., Rahbar, R., Martin, B. G., Murakami, K., Lamorte, S., Thompson, P. K., Berman, H. K., Zúñiga‐Pflücker, J. C., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0037 · Cited by 126
Papayannidis, C., DeAngelo, D. J., Stock, W., Huang, B., Shaik, M. N., Cesari, R., Zheng, X., Reynolds, J. M., English, P. A., Ozeck, M., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.80 · Cited by 122
Cortes, J. E., Smith, B. D., Wang, E. S., Merchant, A. A., Oehler, V. G., Arellano, M. L., DeAngelo, D. J., Pollyea, D. A., Sekeres, M. A., Robak, T., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25238 · Cited by 120
Hegde, G. V., Peterson, K. J., Emanuel, K. M., Mittal, A. K., Joshi, A. D., Dickinson, J. D., Kollessery, G. J., Bociek, R. G., Bierman, P. J., Vose, J. M., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0142 · Cited by 118
Hedgehog–GLI Signaling Inhibition Suppresses Tumor Growth in Squamous Lung Cancer
Huang, L., Walter, V., Hayes, D. N., & Onaitis, M. W. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2195 · Cited by 114
Samon, J. B., Castillo-Martín, M., Hadler, M., Ambesi-Impiobato, A., Paietta, E. M., Racevskis, J., Wiernik, P. H., Rowe, J. M., Jakubczak, J. L., Randolph, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0938 · Cited by 113
Jesus‐Acosta, A. D., Laheru, D. A., Maitra, A., Arcaroli, J. J., Rudek, M. A., Dasari, A. N., Blatchford, P. J., Quackenbush, K. S., & Messersmith, W. A. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0083-8 · Cited by 111
Repurposing itraconazole as an anticancer agent
Tsubamoto, H., Ueda, T., Inoue, K., Sakata, K., Shibahara, H., & Sonoda, T. (2017) · Oncology Letters · doi:10.3892/ol.2017.6325 · Cited by 107
Huang, J., Li, C., Wang, Y., Lv, H., Guo, Y., Dai, H., Wicha, M. S., Chang, A. E., & Li, Q. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.07.006 · Cited by 107
Jia, D., Li, L., Andrew, S., Allan, D., Li, X., Lee, J., Ji, G., Yao, Z., Gadde, S., Figeys, D., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.319 · Cited by 105
Cancer stem cells as targets for immunotherapy
Codd, A. S., Kanaseki, T., Torigoe, T., & Tabi, Z. (2017) · Immunology · doi:10.1111/imm.12866 · Cited by 102
Kim, J. E., Singh, R. R., Cho‐Vega, J. H., Drakos, E., Davuluri, Y., Khokhar, F. A., Fayad, L., Medeiros, L. J., & Vega, F. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.98 · Cited by 99
Arco, P. G., Kashiwagi, M., Jackson, A. F., Naito, T., Zhang, J., Liu, F., Kee, B. L., Vooijs, M., Radtke, F., Redondo, J. M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.008 · Cited by 99
Schulenburg, A., Blatt, K., Cerny‐Reiterer, S., Sadovnik, I., Herrmann, H., Marian, B., Grunt, T. W., Zielinski, C. C., & Valent, P. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0113-9 · Cited by 98
Verteporfin inhibits growth of human glioma in vitro without light activation
Al‐Moujahed, A., Brodowska, K., Stryjewski, T. P., Efstathiou, N. E., Vasilikos, I., Cichy, J., Miller, J. W., Gragoudas, E. S., & Vavvas, D. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-07632-8 · Cited by 98
Anti-CD47 Antibody As a Targeted Therapeutic Agent for Human Lung Cancer and Cancer Stem Cells
Liu, L., Zhang, L., Yang, L., Li, H., Li, R., Yu, J., Yang, L., Wei, F., Yan, C., Sun, Q., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00404 · Cited by 96
Pant, S., Jones, S. F., Kurkjian, C. D., Infante, J. R., Moore, K. N., Burris, H. A., McMeekin, D. S., Benhadji, K. A., Patel, B. K. R., Frenzel, M., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.021 · Cited by 94
PRKCI promotes immune suppression in ovarian cancer
Sarkar, S., Bristow, C. A., Dey, P., Rai, K., Perets, R., Ramirez-Cardenas, A., Malasi, S., Huang-Hobbs, E., Haemmerle, M., Wu, S. Y., et al. (2017) · Genes & Development · doi:10.1101/gad.296640.117 · Cited by 93
Ally, M. S., Ransohoff, K. J., Sarin, K. Y., Atwood, S. X., Rezaee, M., Bailey, I., Kim, J., Beachy, P. A., Chang, A. L. S., Oro, A. E., et al. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.5473 · Cited by 93
Locatelli, M., Aftimos, P. G., Dees, E. C., LoRusso, P. M., Pegram, M. D., Awada, A. H., Huang, B., Cesari, R., Jiang, Y., Shaik, M. N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13727 · Cited by 93
Srivastava, R. K., Zaid‐Kaylani, S., Edrees, N., Li, C., Talwelkar, S. S., Xu, J., Palle, K., Pressey, J. G., & Athar, M. (2014) · Oncotarget · doi:10.18632/oncotarget.2569 · Cited by 92
She, M., Xinqing, N., Chen, X., Li, J., Zhou, M., He, Y., Le, Y., & Guo, K. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.017 · Cited by 92
Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
Steg, A. D., Katre, A. A., Bevis, K. S., Ziebarth, A., Dobbin, Z. C., Shah, M. M., Alvarez, R. D., & Landen, C. N. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-1058 · Cited by 90
Yu, J., Chen, L., Cui, B., Wu, C. C. N., Choi, M. Y., Chen, Y., Zhang, L., Rassenti, L. Z., Widhopf, G. F., & Kipps, T. J. (2016) · Leukemia · doi:10.1038/leu.2016.368 · Cited by 90
Chen, Q., Xu, R., Zeng, C., Lu, Q., Huang, D., Shi, C., Zhang, W., Deng, L., Yan, R., Rao, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088386 · Cited by 87
Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy
Gu, J.-W., Rizzo, P., Pannuti, A., Golde, T. E., Osborne, B. A., & Miele, L. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-7 · Cited by 87
Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
Didiášová, M., Singh, R. K., Wilhelm, J., Kwapiszewska, G., Wujak, L. A., Zakrzewicz, D., Schaefer, L., Markart, P., Seeger, W., Lauth, M., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600892rr · Cited by 84
Astudillo, L., Silva, T. G. D., Wang, Z., Han, X., Jin, K., VanWye, J., Zhu, X., Weaver, K. L., Oashi, T., Lopes, P. E. M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0061 · Cited by 83
Hu, Z. I., Bendell, J. C., Bullock, A., LoConte, N. K., Hatoum, H., Ritch, P., Hool, H., Leach, J. W., Sanchez, J., Sohal, D. P. S., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2425 · Cited by 82
Barr, M. P., Gray, S. G., Gately, K. A., Hams, E., Fallon, P. G., Davies, A. M., Richard, D. J., Pidgeon, G. P., & O'Byrne, K. J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0310-8 · Cited by 81
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL
Wang, L., Shalek, A. K., Lawrence, M. S., Ding, R., Gaublomme, J. T., Pochet, N. L. M. M., Stojanov, P., Sougnez, C. L., Shukla, S. A., Stevenson, K. E., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552067 · Cited by 81
Smith, D. C., Rosen, L. S., Chugh, R. K., Goldman, J. W., Xu, L., Kapoun, A. M., Brachmann, R. K., Dupont, J., Stagg, R., Tolcher, A. W., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2540 · Cited by 81
Richter, S., Bedard, P. L., Chen, E. X., Clarke, B. A., Tran, B., Hotte, S. J., Stathis, A., Hirte, H. W., Razak, A. R. A., Reedijk, M., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9965-4 · Cited by 80
Lockhart, A. C., Bauer, T. M., Aggarwal, C., Lee, C. B., Harvey, R. D., Cohen, R. B., Sedarati, F., Nip, T. K., Faessel, H. M., Dash, A. B., et al. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0610-0 · Cited by 78
Piha-Paul, S. A., Münster, P. N., Hollebecque, A., Argilés, G., Dajani, O. F., Cheng, J., Wang, R., Swift, A., Tosolini, A., & Gupta, S. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.06.115 · Cited by 77
Bendell, J. C., Andre, V., Ho, A. L., Kudchadkar, R. R., Migden, M. R., Infante, J. R., Tiu, R. V., Pitou, C., Tucker, T., Brail, L. H., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0723 · Cited by 75
McKeage, M. J., Kotasek, D., Markman, B., Hidalgo, M., Millward, M. J., Jameson, M. B., Harris, D. L., Stagg, R. J., Kapoun, A. M., Xu, L., et al. (2018) · Targeted Oncology · doi:10.1007/s11523-017-0543-0 · Cited by 74
Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells
Desch, P., Asslaber, D., Kern, D., Schnidar, H., Mangelberger, D., Alinger, B., Stöcher, M., Hofbauer, S., Neureiter, D., Tinhofer, I., et al. (2010) · Oncogene · doi:10.1038/onc.2010.243 · Cited by 71
Wnt5a promotes Frizzled-4 signalosome assembly by stabilizing cysteine-rich domain dimerizationPreprint
DeBruine, Z. J., Ke, J., Harikumar, K. G., Gu, X., Borowsky, P., Williams, B. O., Xu, W., Miller, L. J., Xu, H. E., & Melcher, K. (2017) · Genes & Development · doi:10.1101/gad.298331.117 · Cited by 71
Cisplatin induces stemness in ovarian cancer
Wiechert, A. C., Saygin, C., Thiagarajan, P. S., Rao, V. S., Hale, J. S., Gupta, N., Hitomi, M., Nagaraj, A. B., DiFeo, A. V., Lathia, J. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8852 · Cited by 70
Agarwal, P., Zhang, B., Ho, Y., Cook, A., Li, L., Mikhail, F. M., Wang, Y., McLaughlin, M. E., & Bhatia, R. (2016) · Blood · doi:10.1182/blood-2016-05-714089 · Cited by 69
Ko, A. H., Chiorean, E. G., Kwak, E. L., Lenz, H., Nadler, P. I., Wood, D. L., Fujimori, M., Inada, T., Kouji, H., & McWilliams, R. R. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.e15721 · Cited by 69
Cited by
Cancer stem cell–immune cell crosstalk in tumour progression
Bayik, D., & Lathia, J. D. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00366-w · Cited by 561
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Metabolism of Amino Acids in Cancer
Wei, Z., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 429
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 401
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Zheng, P., Zhou, C., Lu, L., Liu, B., & Ding, Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02485-0 · Cited by 352
Metadata
- Authors
- Clara, J. A., Monge, C., Yang, Y., & Takebe, N.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2019-12-02
- Volume
- 17
- Issue
- 4
- Pages
- 204-232
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2991163352
- Cited by
- 752
- References
- 257
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.